Science Explorer Back to mapMap
Discussion
Researcher · AstraZeneca (Sweden) · Sweden

Jan A. M. Neelissen

Jan A. M. Neelissen publishes mostly in Physiology, Computational Theory and Mathematics and Dermatology, on topics such as Alzheimer's disease research and treatments, Computational Drug Discovery Methods and Advancements in Transdermal Drug Delivery.

OpenAlex
World rank
#1,999,563
of 7,710,434 ranked researchers
Rank in Sweden
#25,880
of 71,437
Works
26
Citations
999
Citations per work
38.4
h-index
14
i10-index 14Top 42% in Physiology (Medicine)
Jan A. M. Neelissen

What does Jan A. M. Neelissen research?

Jan A. M. Neelissen's work is mostly in Medicine (31%), Computer Science (9%), Pharmacology, Toxicology and Pharmaceutics (8%).

Everything else: 12 works · 45.4% of their workHealth Sciences: 8 works · 30.6% of their workMedicine: 8 works · 30.6% of their workPhysiology: 4 works · 16.0% of their workDermatology: 2 works · 9.3% of their workPsychiatry and Mental health: 1 works · 5.3% of their workLife Sciences: 4 works · 14.7% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 8.0% of their workPharmaceutical Science: 2 works · 8.0% of their workAgricultural and Biological Sciences: 2 works · 6.7% of their workFood Science: 2 works · 6.7% of their workPhysical Sciences: 2 works · 9.3% of their workComputer Science: 2 works · 9.3% of their workComputational Theory and Mathematics: 2 works · 9.3% of their workTHEIR WORKJan A. M.Neelissen26works
Life Sciences15%Physical Sciences9%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1245.4%
    1. Medicine830.6%
    1. Pharmacology, Toxicology and Pharmaceutics28.0%
    2. Agricultural and Biological Sciences26.7%
    1. Computer Science29.3%
  1. 1Physiology16% of their works
  2. 2Computational Theory and Mathematics9% of their works
  3. 3Dermatology9% of their works
  4. 4Pharmaceutical Science8% of their works
  5. 5Food Science7% of their works
  6. 6Psychiatry and Mental health5% of their works

Research topics

Which keywords describe Jan A. M. Neelissen's research?

The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Molecular Docking, Virtual Screening, Microneedles, Solid Lipid Nanoparticles and Filaggrin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Amyloid Hypothesis111 topic
  2. Tau Pathology111 topic
  3. Alzheimer's Disease82 topics
  4. Molecular Docking71 topic
  5. Virtual Screening71 topic
  6. Microneedles61 topic
  7. Solid Lipid Nanoparticles61 topic
  8. Filaggrin51 topic
  9. Skin Microbiome51 topic
  10. ATP-dependent Transporters41 topic
  11. Acetylcholinesterase41 topic
  12. Cholinesterase Inhibitors41 topic
  13. Dementia41 topic
  14. Mild Cognitive Impairment41 topic
  15. Multidrug Resistance41 topic
  16. Antimicrobial Activity31 topic
  17. Essential Oils31 topic

Where does Jan A. M. Neelissen work?

Jan A. M. Neelissen's main affiliation in the publication record is AstraZeneca (Sweden), Sweden.

How many publications and citations does Jan A. M. Neelissen have?

OpenAlex counts 26 works and 999 citations for Jan A. M. Neelissen, an h-index of 14, ranking #1,999,563 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jan A. M. Neelissen. Posts are plain text and can be reported.